Semi-Annual Statement Of Cash Flows

Chordia Therapeutics,Inc - Filing #7267458

Concept As at
2025-02-28
2024-09-01 to
2025-02-28
As at
2024-08-31
As at
2024-02-29
2023-09-01 to
2024-02-29
As at
2023-08-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-975,131,000 JPY
-801,401,000 JPY
Depreciation
1,223,000 JPY
2,111,000 JPY
Increase (decrease) in provision for bonuses
JPY
-15,720,000 JPY
Other, net
97,098,000 JPY
-148,601,000 JPY
Subtotal
-1,163,032,000 JPY
-1,067,245,000 JPY
Income taxes paid
-2,420,000 JPY
-2,420,000 JPY
Net cash provided by (used in) operating activities
-1,114,470,000 JPY
-1,052,483,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-667,000 JPY
-178,000 JPY
Net cash provided by (used in) investing activities
-667,000 JPY
-178,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
61,580,000 JPY
JPY
Net increase (decrease) in cash and cash equivalents
-1,053,557,000 JPY
-1,052,661,000 JPY
Cash and cash equivalents
3,276,066,000 JPY
4,329,624,000 JPY
3,746,373,000 JPY
4,799,035,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.